Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Complex narratives of health, stigma and control: Antimicrobial resistance screening among non-hospitalized refugees.

Kamenshchikova A, Wolffs PFG, Hoebe CJ, Penders J, Horstman K.

Soc Sci Med. 2018 Sep;212:43-49. doi: 10.1016/j.socscimed.2018.07.012. Epub 2018 Jul 7.

PMID:
30005223
2.

"Strangers in the ER": Quality indicators and third party interference in Dutch emergency care.

Moes FB, Houwaart ES, Delnoij DMJ, Horstman K.

J Eval Clin Pract. 2018 Mar 6. doi: 10.1111/jep.12900. [Epub ahead of print]

PMID:
29508476
3.

Photovoicing the neighbourhood: Understanding the situated meaning of intangible places for ageing-in-place.

van Hees S, Horstman K, Jansen M, Ruwaard D.

Health Place. 2017 Nov;48:11-19. doi: 10.1016/j.healthplace.2017.08.007. Epub 2017 Sep 23.

4.

Contested evidence: a Dutch reimbursement decision taken to court - CORRIGENDUM.

Moes F, Houwaart E, Delnoij D, Horstman K.

Health Econ Policy Law. 2017 Jul;12(3):401. doi: 10.1017/S1744133116000360. No abstract available.

PMID:
28573963
5.

'Foreigners', 'ethnic minorities', and 'non-Western allochtoons': an analysis of the development of 'ethnicity' in health policy in the Netherlands from 1970 to 2015.

Helberg-Proctor A, Meershoek A, Krumeich A, Horstman K.

BMC Public Health. 2017 Jan 31;17(1):132. doi: 10.1186/s12889-017-4063-8.

6.

Contested evidence: a Dutch reimbursement decision taken to court.

Moes F, Houwaart E, Delnoij D, Horstman K.

Health Econ Policy Law. 2017 Jul;12(3):325-344. doi: 10.1017/S1744133116000281. Epub 2016 Nov 15. Erratum in: Health Econ Policy Law. 2017 Jul;12(3):401.

PMID:
27842620
7.

Lifestyle Vaccines and Public Health: Exploring Policy Options for a Vaccine to Stop Smoking.

Wolters A, de Wert G, van Schayck OC, Horstman K.

Public Health Ethics. 2016 Jul;9(2):183-197. Epub 2016 Mar 14.

8.

Responsible use of media supports 'critical public health literacy'.

Knibbe M, de Vries M, Horstman K.

J Public Health (Oxf). 2017 Jun 1;39(2):353-357. doi: 10.1093/pubmed/fdw036. No abstract available.

PMID:
27099163
9.

Taming the fear of voice: Dilemmas in maintaining a high vaccination rate in the Netherlands.

Geelen E, van Vliet H, de Hoogh P, Horstman K.

Soc Sci Med. 2016 Mar;153:12-9. doi: 10.1016/j.socscimed.2016.01.051. Epub 2016 Feb 2.

PMID:
26867207
10.

Conflicting notions of citizenship in old age: An analysis of an activation practice.

van Hees S, Horstman K, Jansen M, Ruwaard D.

J Aging Stud. 2015 Dec;35:178-89. doi: 10.1016/j.jaging.2015.09.001. Epub 2015 Sep 29.

PMID:
26568227
11.

Ethnicity in Dutch health research: situating scientific practice.

Helberg-Proctor A, Meershoek A, Krumeich A, Horstman K.

Ethn Health. 2016 Oct;21(5):480-97. doi: 10.1080/13557858.2015.1093097. Epub 2015 Oct 15.

PMID:
26469552
12.

Engaging cultural resources to promote mental health in Dutch LSES neighborhoods: study of a community-based participatory media project.

Knibbe M, de Vries M, Horstman K.

Health Promot Int. 2017 Jun 1;32(3):567-576. doi: 10.1093/heapro/dav095.

PMID:
26420745
13.

How can we assess the value of complex medical innovations in practice?

Abrishami P, Boer A, Horstman K.

Expert Rev Pharmacoecon Outcomes Res. 2015 Jun;15(3):369-71. doi: 10.1586/14737167.2015.1037834.

PMID:
25963313
14.

International clinical trials, cardiovascular disease and treatment options in the Russian Federation: research and treatment in practice.

Zvonareva O, Engel N, Martsevich S, de Wert G, Horstman K.

Soc Sci Med. 2015 Mar;128:255-62. doi: 10.1016/j.socscimed.2015.01.038. Epub 2015 Jan 22.

PMID:
25635372
15.

[Living a good live with e-health: anticipating ethical consequences and monitoring them].

Horstman K.

Ned Tijdschr Geneeskd. 2014;158:A8516. Dutch.

PMID:
25534268
16.

Value in the Making: Harvesting the Value of Complex Medical Innovations in Practice.

Abrishami P, Boer A, Horstman K.

Value Health. 2014 Nov;17(7):A324. doi: 10.1016/j.jval.2014.08.571. Epub 2014 Oct 26. No abstract available.

17.

Understanding the adoption dynamics of medical innovations: affordances of the da Vinci robot in the Netherlands.

Abrishami P, Boer A, Horstman K.

Soc Sci Med. 2014 Sep;117:125-33. doi: 10.1016/j.socscimed.2014.07.046. Epub 2014 Jul 18.

PMID:
25063968
18.

Nicotine vaccination--does it have a future?

van Schayck OC, Horstman K, Vuurman E, de Wert G, Kotz D.

Addiction. 2014 Aug;109(8):1223-5. doi: 10.1111/add.12569. Epub 2014 Jun 3. No abstract available.

PMID:
24894565
19.

Vaccination against smoking: an annotated agenda for debate. A review of scientific journals, 2001-13.

Wolters A, de Wert G, van Schayck OC, Horstman K.

Addiction. 2014 Aug;109(8):1268-73. doi: 10.1111/add.12572. Epub 2014 Jun 3. Review.

PMID:
24889653
20.

Constructing a trial as a personal lifestyle change project: participants' experiences in a clinical study for nicotine vaccination.

Wolters A, de Wert G, van Schayck O, Horstman K.

Soc Sci Med. 2014 Mar;104:116-23. doi: 10.1016/j.socscimed.2013.12.011. Epub 2013 Dec 18.

PMID:
24581069
21.

Disembodied abilities: sick role and participation in 'activating' return-to-work practices.

van Hal L, Meershoek A, Nijhuis F, Horstman K.

Soc Sci Med. 2013 Nov;96:9-16. doi: 10.1016/j.socscimed.2013.07.003. Epub 2013 Jul 13.

PMID:
24034946
22.

Ethical review: Standardizing procedures and local shaping of ethical review practices.

Jaspers P, Houtepen R, Horstman K.

Soc Sci Med. 2013 Dec;98:311-8. doi: 10.1016/j.socscimed.2013.03.043. Epub 2013 Jul 12.

PMID:
23921211
23.

A sociological perspective on "the unmotivated client": public accountability and professional work methods in vocational rehabilitation.

van Hal L, Meershoek A, Nijhuis F, Horstman K.

Disabil Rehabil. 2013 May;35(10):809-18. doi: 10.3109/09638288.2012.709303. Epub 2012 Aug 20.

PMID:
22900601
24.

Effects of transplacental 17-α-ethynyl estradiol or bisphenol A on the developmental profile of steroidogenic acute regulatory protein in the rat testis.

Horstman KA, Naciff JM, Overmann GJ, Foertsch LM, Richardson BD, Daston GP.

Birth Defects Res B Dev Reprod Toxicol. 2012 Aug;95(4):318-25. doi: 10.1002/bdrb.21020. Epub 2012 Jul 2.

PMID:
22752971
25.

Unravelling fears of genetic discrimination: an exploratory study of Dutch HCM families in an era of genetic non-discrimination acts.

Geelen E, Horstman K, Marcelis CL, Doevendans PA, Van Hoyweghen I.

Eur J Hum Genet. 2012 Oct;20(10):1018-23. doi: 10.1038/ejhg.2012.53. Epub 2012 Mar 28.

26.

The 'empowered client' in vocational rehabilitation: the excluding impact of inclusive strategies.

van Hal LB, Meershoek A, Nijhuis F, Horstman K.

Health Care Anal. 2012 Sep;20(3):213-30. doi: 10.1007/s10728-011-0182-z.

27.

Constructing "best interests": genetic testing of children in families with hypertrophic cardiomyopathy.

Geelen E, Van Hoyweghen I, Doevendans PA, Marcelis CL, Horstman K.

Am J Med Genet A. 2011 Aug;155A(8):1930-8. doi: 10.1002/ajmg.a.34107. Epub 2011 Jul 7.

PMID:
21739592
28.

The paradox of public health genomics: definition and diagnosis of familial hypercholesterolaemia in three European countries.

Aarden E, Van Hoyweghen I, Horstman K.

Scand J Public Health. 2011 Aug;39(6):634-9. doi: 10.1177/1403494811414241. Epub 2011 Jul 5.

PMID:
21730009
29.

Genetics, health care, family and kinship in a global perspective: situated processes of co-construction.

Horstman K, Finkler K.

Soc Sci Med. 2011 Jun;72(11):1739-42. doi: 10.1016/j.socscimed.2011.05.001. Epub 2011 May 14. No abstract available. Erratum in: Soc Sci Med. 2011 Nov;73(9):1444.

PMID:
21663802
30.

Constructing access in predictive medicine. Comparing classification for hereditary breast cancer risks in England, Germany and the Netherlands.

Aarden E, Van Hoyweghen I, Horstman K.

Soc Sci Med. 2011 Feb;72(4):553-9. doi: 10.1016/j.socscimed.2010.11.033. Epub 2010 Dec 15.

PMID:
21208700
31.

Making genetics not so important: family work in dealing with familial hypertrophic cardiomyopathy.

Geelen E, Van Hoyweghen I, Horstman K.

Soc Sci Med. 2011 Jun;72(11):1752-9. doi: 10.1016/j.socscimed.2010.06.012. Epub 2010 Jun 25.

PMID:
20630643
32.

A question of style: method, integrity and the meaning of proper science.

Penders B, Vos R, Horstman K.

Endeavour. 2009 Sep;33(3):93-8. doi: 10.1016/j.endeavour.2009.07.001. Epub 2009 Aug 8.

PMID:
19665231
33.

Side effects of problem-solving strategies in large-scale nutrition science: towards a diversification of health.

Penders B, Vos R, Horstman K.

Br J Nutr. 2009 Nov;102(10):1400-3. doi: 10.1017/S0007114509990651. Epub 2009 Jun 17.

PMID:
19531271
34.

Providing preimplantation genetic diagnosis in the United Kingdom, The Netherlands and Germany: a comparative in-depth analysis of health-care access.

Aarden E, Van Hoyweghen I, Vos R, Horstman K.

Hum Reprod. 2009 Jul;24(7):1542-7. doi: 10.1093/humrep/dep054. Epub 2009 Mar 11.

PMID:
19279036
35.

Sensitization: reciprocity and reflection in scientific practice. Science & Society Series on Convergence Research.

Penders B, Vos R, Horstman K.

EMBO Rep. 2009 Mar;10(3):205-8. doi: 10.1038/embor.2009.16. Epub 2009 Feb 20. No abstract available.

36.

A ferry between cultures. Crafting a new profession at the intersection of science and society.

Penders B, Horstman K, Vos R.

EMBO Rep. 2008 Aug;9(8):709-13. doi: 10.1038/embor.2008.134. Epub 2008 Jul 18. No abstract available.

37.

European practices of genetic information and insurance: lessons for the Genetic Information Nondiscrimination Act.

Van Hoyweghen I, Horstman K.

JAMA. 2008 Jul 16;300(3):326-7. doi: 10.1001/jama.2008.62. No abstract available.

PMID:
18632546
38.

Engineering flesh: towards an ethics of lived integrity.

Derksen MH, Horstman K.

Med Health Care Philos. 2008 Sep;11(3):269-83. doi: 10.1007/s11019-007-9115-x. Epub 2008 Feb 5.

39.

Genetic 'risk carriers' and lifestyle 'risk takers'. Which risks deserve our legal protection in insurance?

Van Hoyweghen I, Horstman K, Schepers R.

Health Care Anal. 2007 Sep;15(3):179-93. Epub 2007 Feb 21.

PMID:
17922196
40.

Proper science in moist biology.

Penders B, Horstman K, Vos R.

EMBO Rep. 2007 Jul;8(7):613. No abstract available.

41.

Making the normal deviant: the introduction of predictive medicine in life insurance.

Van Hoyweghen I, Horstman K, Schepers R.

Soc Sci Med. 2006 Sep;63(5):1225-35. Epub 2006 May 12.

PMID:
16697510
42.

'Genetics is not the issue': insurers on genetics and life insurance.

Van Hoyweghen I, Horstman K, Schepers R.

New Genet Soc. 2005 Apr;24(1):79-98.

PMID:
16552918
43.

Voice beyond choice: hesitant voice in public debates about genetics in health care.

Benschop R, Horstman K, Vos R.

Health Care Anal. 2003 Jun;11(2):141-50. Review.

PMID:
14567477
44.

Evidence-based medicine and power shifts in health care systems.

Vos R, Houtepen R, Horstman K.

Health Care Anal. 2002;10(3):319-28.

PMID:
12769419
45.
46.

Technology and the management of trust in insurance medicine.

Horstman K.

Theor Med Bioeth. 2000 Jan;21(1):39-61.

PMID:
10927968
47.

[The management of disability: the political debate on the Workmen's Compensation Act and the development of the medical market].

Horstman K.

Tijdschr Soc Geschied. 1999;25(4):383-406. Dutch. No abstract available.

PMID:
22532992
48.

Drainage pits in cohesionless materials: implications for surface of Phobos.

Horstman KC, Melosh HJ.

J Geophys Res. 1989 Sep 10;94(B9):12433-41.

PMID:
11539795
49.

[The history of medical practice; between social history and historical sociology].

Horstman K.

Ned Tijdschr Geneeskd. 1989 Apr 15;133(15):781-4. Dutch. No abstract available.

PMID:
2654663

Supplemental Content

Loading ...
Support Center